These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31415763)

  • 1. The effect of P2X7R-mediated Ca
    Ma Y; Zhao H; Chile C; Wang C; Zheng J; Song R; Zou H; Gu J; YanYuan ; Bian J; Liu Z
    Exp Cell Res; 2019 Oct; 383(2):111555. PubMed ID: 31415763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of P2X7R- mediated Ca
    Ma Y; Ran D; Zhao H; Shi X; Song R; Zou H; Liu Z
    Life Sci; 2022 Mar; 293():120337. PubMed ID: 35074408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential mechanisms of osteoprotegerin-induced damage to osteoclast adhesion structures via P2X7R-mediated MAPK signaling.
    Ma Y; Shi X; Zhao H; Song R; Zou H; Zhu J; Liu Z
    Int J Mol Med; 2022 May; 49(5):. PubMed ID: 35266010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.
    Li X; Ye JX; Xu MH; Zhao MD; Yuan FL
    Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin disrupts peripheral adhesive structures of osteoclasts by modulating Pyk2 and Src activities.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Zhang X; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cell Adh Migr; 2016 May; 10(3):299-309. PubMed ID: 26743491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch2 signaling promotes osteoclast resorption via activation of PYK2.
    Jin WJ; Kim B; Kim JW; Kim HH; Ha H; Lee ZH
    Cell Signal; 2016 May; 28(5):357-365. PubMed ID: 26829213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation.
    Fu Y; Gu J; Wang Y; Yuan Y; Liu X; Bian J; Liu ZP
    J Vet Sci; 2015; 16(2):151-6. PubMed ID: 25549213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M; Takahashi N; Udagawa N; Miyaura C; Suda K; Woo JT; Martin TJ; Nagai K; Suda T
    Endocrinology; 2000 Dec; 141(12):4711-9. PubMed ID: 11108286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survival.
    Tanabe N; Wheal BD; Kwon J; Chen HH; Shugg RP; Sims SM; Goldberg HA; Dixon SJ
    J Biol Chem; 2011 Nov; 286(46):39871-81. PubMed ID: 21940634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT/mTOR/ULK1-mediated autophagic pathway.
    Zhao H; Sun Z; Ma Y; Song R; Yuan Y; Bian J; Gu J; Liu Z
    J Cell Physiol; 2020 Mar; 235(3):3002-3012. PubMed ID: 31535378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
    Cao B; Dai X; Wang W
    J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
    Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
    Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress induced by P2X7 receptor stimulation in murine macrophages is mediated by c-Src/Pyk2 and ERK1/2.
    Martel-Gallegos G; Casas-Pruneda G; Ortega-Ortega F; Sánchez-Armass S; Olivares-Reyes JA; Diebold B; Pérez-Cornejo P; Arreola J
    Biochim Biophys Acta; 2013 Oct; 1830(10):4650-9. PubMed ID: 23711511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways.
    Yeon JT; Ryu BJ; Choi SW; Heo JC; Kim KJ; Son YJ; Kim SH
    Amino Acids; 2014 Nov; 46(11):2605-14. PubMed ID: 25216923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
    Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
    J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.